MustGrow Biologics Completes Acquisition of NexusBioAg
MustGrow Biologics Corp (TSXV: MGRO) (OTCQB: MGROF) has completed the acquisition of NexusBioAg from Univar Solutions Canada through an Asset Purchase Agreement dated December 31, 2024. The acquisition positions MustGrow as a fully integrated provider of biological and regenerative agriculture solutions with established sales, marketing, and distribution operations in Canada, with potential U.S. expansion opportunities.
The deal includes a deferred cash payment of approximately $1,662,000, subject to adjustments, and earn-out payments based on gross margin percentages from specific products sold in 2025 and 2026. The TSX Venture Exchange has granted conditional approval for the acquisition. The NexusBioAg division will market existing product lines, MustGrow's proprietary products, and potential third-party offerings, leveraging their experienced sales team and established industry relationships.
MustGrow Biologics Corp (TSXV: MGRO) (OTCQB: MGROF) ha completato l'acquisizione di NexusBioAg da Univar Solutions Canada attraverso un Accordo di Acquisto di Attività datato 31 dicembre 2024. Questa acquisizione posiziona MustGrow come fornitore completamente integrato di soluzioni per l'agricoltura biologica e rigenerativa con operazioni di vendita, marketing e distribuzione già stabilite in Canada, con potenziali opportunità di espansione negli Stati Uniti.
L'accordo include un pagamento in contante posticipato di circa $1.662.000, soggetto a rettifiche, e pagamenti di earn-out basati sulle percentuali di margine lordo di prodotti specifici venduti nel 2025 e 2026. La Borsa valori TSX Venture ha concesso l'approvazione condizionale all'acquisizione. La divisione NexusBioAg commercializzerà le linee di prodotti esistenti, i prodotti proprietari di MustGrow e possibili offerte di terzi, sfruttando il loro esperto team di vendita e le relazioni consolidate nel settore.
MustGrow Biologics Corp (TSXV: MGRO) (OTCQB: MGROF) ha completado la adquisición de NexusBioAg de Univar Solutions Canada a través de un Acuerdo de Compra de Activos fechado el 31 de diciembre de 2024. Esta adquisición posiciona a MustGrow como proveedor completamente integrado de soluciones agrícolas biológicas y regenerativas con operaciones de ventas, marketing y distribución establecidas en Canadá, con oportunidades de expansión potencial en los Estados Unidos.
El acuerdo incluye un pago en efectivo diferido de aproximadamente $1,662,000, sujeto a ajustes, y pagos por rendimiento basado en porcentajes de margen bruto de productos específicos vendidos en 2025 y 2026. La Bolsa de Valores TSX Venture ha otorgado aprobación condicional para la adquisición. La división NexusBioAg comercializará las líneas de productos existentes, los productos propios de MustGrow y posibles ofertas de terceros, aprovechando su experimentado equipo de ventas y relaciones establecidas en la industria.
MustGrow Biologics Corp (TSXV: MGRO) (OTCQB: MGROF)는 2024년 12월 31일자로 Univar Solutions Canada로부터 NexusBioAg를 인수하는 계약을 완료했습니다. 이 인수는 MustGrow를 완전 통합된 생물학적 및 재생 농업 솔루션 제공업체로 자리매김하게 하며, 캐나다 내에서 확립된 판매, 마케팅 및 유통 운영을 비롯해 미국의 확장 기회도 갖추게 됩니다.
이 거래는 약 $1,662,000의 지연된 현금 지급을 포함하며, 이는 조정될 수 있고, 2025년과 2026년에 판매되는 특정 제품의 총 마진 비율에 따라 추가 지급이 이루어집니다. TSX 벤처 거래소는 이 인수에 대해 조건부 승인을 부여했습니다. NexusBioAg 부서는 기존 제품 라인과 MustGrow의 독점 제품 및 제3의 제품 제안을 마케팅하며, 경험이 풍부한 판매 팀과 확립된 산업 관계를 활용할 것입니다.
MustGrow Biologics Corp (TSXV: MGRO) (OTCQB: MGROF) a finalisé l'acquisition de NexusBioAg auprès d'Univar Solutions Canada par le biais d'un Accord d'Achat d'Actifs daté du 31 décembre 2024. Cette acquisition positionne MustGrow en tant que fournisseur complètement intégré de solutions d'agriculture biologique et régénérative avec des opérations de vente, de marketing et de distribution établies au Canada, ainsi que des opportunités d'expansion potentielles aux États-Unis.
L'accord comprend un paiement en espèces différé d'environ $1,662,000, soumis à des ajustements, ainsi que des paiements de performance basés sur les pourcentages de marge brute de produits spécifiques vendus en 2025 et 2026. La Bourse de Toronto Venture a accordé son approbation conditionnelle à l'acquisition. La division NexusBioAg commercialisera les lignes de produits existantes, les produits exclusifs de MustGrow et d'éventuelles offres tierces, tirant parti de son équipe de vente expérimentée et de ses relations établies dans l'industrie.
MustGrow Biologics Corp (TSXV: MGRO) (OTCQB: MGROF) hat den Erwerb von NexusBioAg von Univar Solutions Canada durch einen Asset-Kaufvertrag vom 31. Dezember 2024 abgeschlossen. Der Erwerb positioniert MustGrow als voll integrierten Anbieter von biologischen und regenerativen Landwirtschaftslösungen mit etablierten Verkaufs-, Marketing- und Vertriebsoperationen in Kanada sowie potenziellen Expansionsmöglichkeiten in den USA.
Das Geschäft umfasst eine aufgeschobene Bargeldzahlung von etwa $1.662.000, die Anpassungen unterliegt, sowie Earn-out-Zahlungen basierend auf den Bruttomarge-Prozentsätzen bestimmter Produkte, die 2025 und 2026 verkauft werden. Die TSX Venture Exchange hat die bedingte Genehmigung für den Erwerb erteilt. Die Division NexusBioAg wird bestehende Produktlinien, die proprietären Produkte von MustGrow und potenzielle Angebote Dritter vermarkten und dabei ihr erfahrenes Vertriebsteam sowie die etablierten Geschäftsbeziehungen nutzen.
- Acquisition establishes MustGrow as a fully integrated provider in the biological agriculture sector
- Expected significant sales synergies through enhanced market access
- Reduction in distribution costs for MustGrow's products
- Acquisition includes experienced sales team with established industry relationships
- Potential for U.S. market expansion
- Deferred cash payment obligation of $1,662,000
- Future earn-out payment obligations for 2025 and 2026
Saskatoon, Saskatchewan--(Newsfile Corp. - January 2, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the execution and closing of an Asset Purchase Agreement (the "APA") dated December 31, 2024 with Univar Solutions Canada Ltd. ("Univar Solutions") for the acquisition of certain assets that represent NexusBioAg ("NexusBioAg").
MustGrow's acquisition of NexusBioAg positions the Company as a fully integrated provider of biological and regenerative agriculture solutions with a sales, marketing and distribution division in Canada and the opportunity to expand the division's operations into the U.S. The consideration payable to Univar Solutions pursuant to the APA is (i) a deferred cash payment of approximately
Under MustGrow, this division will market and sell the existing NexusBioAg product lines, MustGrow's owned products and technology, and potentially other third-party products. The NexusBioAg sales and marketing team brings extensive experience in the biological and regenerative agriculture sector to MustGrow's operations, supported by a broad industry network that is uniquely positioned to drive growth and innovation. The NexusBioAg team has well-established relationships with growers, channel partners, and industry influencers. They are adept at commercialization of new biological and regenerative products as well as at leveraging a proven business model. The Company expects significant sales synergies from the acquisition driven by enhanced market access and reduced distribution costs for MustGrow's owned products and technology.
"This synergistic acquisition solidifies MustGrow's position as a fully integrated biological and regenerative agriculture company with an established sales, marketing and distribution division offering the existing NexusBioAg product lines and supporting the commercialization of MustGrow's own innovative products and technologies. Just like MustGrow's own products and technologies, we are committed to growing the NexusBioAg division and we welcome the new team to MustGrow," said Corey Giasson, President & CEO of MustGrow.
About NexusBioAg
NexusBioAg, a division of MustGrow, provides an expanded portfolio of crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. With a diverse collection of inventory and logistics experts, procurement, customer service, agronomists, and sales and marketing experts, NexusBioAg strives to help meet increasingly unique agricultural businesses' needs. Through these strong capabilities, a collaborative team-oriented approach, and a commitment to agricultural integrity, NexusBioAg is helping customers innovate and grow. Learn more at www.nexusbioag.com.
About MustGrow
MustGrow Biologics Corp. is a fully-integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. In North America, MustGrow offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly-owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers. Outside of North America, MustGrow is focused on collaborating with agriculture companies, such as Bayer AG in Europe, the Middle East and Africa, to commercialize MustGrow's wholly-owned proprietary products and technologies. The Company is dedicated to driving shareholder value through on the commercialization and expansion of its intellectual property portfolio of approximately 112 patents that are currently issued and pending, and the sales and distribution of its proprietary and third-party product lines through NexusBioAg. MustGrow is a public traded company (TSXV: MGRO) and has approximately 51.6 million common shares issued and outstanding and 55.7 million shares fully diluted. For further details, please visit www.mustgrow.ca.
Contact Information
Corey Giasson
Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca
MustGrow Forward-Looking Statements
Certain statements included in this news release constitute "forward-looking statements" which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "occur" or "be achieved". Examples of forward-looking statements in this news release include, among others, statements MustGrow makes regarding: the potential expansion of the NexusBioAg division's operations in the U.S.; the precise quantum of the consideration payable to Univar Solutions pursuant to the APA; whether the NexusBioAg division will market and sell the existing NexusBioAg product lines, MustGrow's owned products and technology, and potentially other third-party products; and the expected significant sales synergies from the acquisition driven by enhanced market access and reduced distribution costs for MustGrow's owned products and technology. Forward-Looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will occur at all or have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow's actual results and financial condition to differ materially from those indicated in the forward-looking statements include: any required adjustments to the consideration payable to Univar Solutions pursuant to the APA (in accordance with the terms of the APA); the successful integration of the NexusBioAg division into MustGrow's existing operations; changes to market conditions as a result of lower farm revenues due to lower yield because of weather events or lower crop prices, delayed planting due to weather impacting the application of additional technologies, reduced farm gate cash flow or credit ratings, higher farm input costs due to inflation, supply chain issues in production and shipping, increased competition from new products or lower prices for competing products, retail consolidation in the agribusiness sector, labour market issues, and third party product supply issues; and the risks described in MustGrow's Annual Information Form for the year ended December 31, 2023 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available on SEDAR+ at www.sedarplus.ca. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
Neither the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.
© 2025 MustGrow Biologics Corp. All rights reserved.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235710
FAQ
What is the purchase price for MustGrow's (MGROF) acquisition of NexusBioAg?
When did MustGrow (MGROF) complete the NexusBioAg acquisition?
What are the expected synergies from MustGrow's NexusBioAg acquisition?
How will the NexusBioAg acquisition affect MustGrow's market presence?
What products will the acquired NexusBioAg division sell under MustGrow?
